EC
IMGN

EdgeRock Capital’s Immunogen Inc IMGN Stock Holding History

EdgeRock Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-49
Closed -$1.43K – 328
2023
Q4 		$1.43K Buy
+49
New +$976 ﹤0.01% 289
2022
Q4 		– Sell
-49
Closed – – 426
2022
Q3 		$0 Buy
+49
New +$258 ﹤0.01% 428

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

EdgeRock Capital's IMGN Position: Q1 2024 in Review

EdgeRock Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 49 shares — an estimated $1.43K sold.

EdgeRock Capital first reported a position in IMGN in Q3 2022 and held it in 2 quarters. The position peaked at $1.43K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • EdgeRock Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • EdgeRock Capital sold 49 Immunogen Inc shares in Q1 2024, an estimated $1.43K.
  • EdgeRock Capital first reported a position in Immunogen Inc in Q3 2022 and held it in 2 quarters.
  • EdgeRock Capital's Immunogen Inc position peaked at $1.43K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on EdgeRock Capital's 13F filing for Q1 2024, filed 15 May 2024.